Discover
JAGX
Jaguar Health, Inc.
3.04
2 x 2.17
2 x 3.77
bid
ask
+
0.04
1.33%
2 @ 05:39 AM
3.04 +0.00 (0.00%)
| Ytd | -90.67% | |
| 1y | -96.53% |
2.86
day range
3.07
2.12
52 week range
97.65
| Open | 2.91 | Prev Close | 3.00 | Low | 2.86 | High | 3.07 | Mkt Cap | 14.65M |
| Vol | 47.77K | Avg Vol | 89.87K | EPS | -695.50 | P/E | N/A | Forward P/E | -0.37 |
| Beta | 0.88 | Short Ratio | 1.12 | Inst. Own | 1.96% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-13 | 50-d Avg | 4.40 | 200-d Avg | 31.57 | 1yr Est | 6.00 |
| Income Statement | |||
| Total Revenue | 20.27M | ||
| Revenues (USD) | 20.27M | ||
| Cost of Revenue | 1.16M | ||
| Gross Profit | 19.11M | ||
| Operating Expenses | 8.93M | ||
| Research and Development Expense | 3.93M | ||
| Selling, General and Administrative Expense | 5.00M | ||
| Operating Income | 10.18M | ||
| Interest Expense | 699.00K | ||
| Net Income | 8.85M | ||
| Net Income Common Stock | -7.01M | ||
| Net Income Common Stock (USD) | -7.01M | ||
| Consolidated Income | 8.72M | ||
| Net Income to Non-Controlling Interests | -126.00K | ||
| Earnings per Basic Share | -13.60 | ||
| Earnings per Basic Share (USD) | -13.60 | ||
| Earnings per Diluted Share | -13.60 | ||
| Earning Before Interest & Taxes (EBIT) | 9.55M | ||
| Earning Before Interest & Taxes (USD) | 9.55M | ||
| Preferred Dividends Income Statement Impact | 15.86M | ||
| Weighted Average Shares | 515.79K | ||
| Weighted Average Shares Diluted | 515.79K | ||
| Balance Sheet | |||
| Cash and Equivalents | 10.06M | ||
| Cash and Equivalents (USD) | 10.06M | ||
| Trade and Non-Trade Receivables | 280.00K | ||
| Current Assets | 20.21M | ||
| Property, Plant & Equipment Net | 1.50M | ||
| Total Assets | 37.43M | ||
| Debt Current | 22.34M | ||
| Total Debt | 34.31M | ||
| Current Liabilities | 40.69M | ||
| Debt Non-Current | 11.97M | ||
| Total Liabilities | 53.19M | ||
| Accumulated Retained Earnings (Deficit) | -391.07M | ||
| Accumulated Other Comprehensive Income | -1.24M | ||
| Shareholders Equity | -14.18M | ||
| Shareholders Equity (USD) | -14.18M | ||
| Assets Non-Current | 17.22M | ||
| Total Debt (USD) | 34.31M | ||
| Deferred Revenue | 510.00K | ||
| Goodwill and Intangible Assets | 15.55M | ||
| Inventory | 7.82M | ||
| Liabilities Non-Current | 12.50M | ||
| Trade and Non-Trade Payables | 4.96M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 520.00K | ||
| Net Cash Flow from Financing | -6.61M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | 2.23M | ||
| Issuance (Repayment) of Debt Securities | -6.61M | ||
| Net Cash Flow from Operations | 8.83M | ||
| Effect of Exchange Rate Changes on Cash | 17.00K | ||
| Share Based Compensation | 155.00K | ||